- Home
- KTOS vs BDTX Comparison
KTOS vs BDTX Comparison
Compare KTOS & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTOS
- BDTX
- Stock Information
- Founded
- KTOS 1994
- BDTX 2014
- Country
- KTOS United States
- BDTX United States
- Employees
- KTOS N/A
- BDTX N/A
- Industry
- KTOS Military/Government/Technical
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KTOS Industrials
- BDTX Health Care
- Exchange
- KTOS Nasdaq
- BDTX Nasdaq
- Market Cap
- KTOS 6.2B
- BDTX 132.5M
- IPO Year
- KTOS 1999
- BDTX 2020
- Fundamental
- Price
- KTOS $44.35
- BDTX $2.58
- Analyst Decision
- KTOS Buy
- BDTX Strong Buy
- Analyst Count
- KTOS 10
- BDTX 6
- Target Price
- KTOS $43.20
- BDTX $14.83
- AVG Volume (30 Days)
- KTOS 4.9M
- BDTX 1.3M
- Earning Date
- KTOS 08-06-2025
- BDTX 08-05-2025
- Dividend Yield
- KTOS N/A
- BDTX N/A
- EPS Growth
- KTOS N/A
- BDTX N/A
- EPS
- KTOS 0.13
- BDTX 0.09
- Revenue
- KTOS $1,161,700,000.00
- BDTX $70,000,000.00
- Revenue This Year
- KTOS $15.46
- BDTX N/A
- Revenue Next Year
- KTOS $15.70
- BDTX N/A
- P/E Ratio
- KTOS $385.63
- BDTX $29.29
- Revenue Growth
- KTOS 7.32
- BDTX N/A
- 52 Week Low
- KTOS $17.91
- BDTX $1.20
- 52 Week High
- KTOS $47.09
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- KTOS 59.01
- BDTX 60.65
- Support Level
- KTOS $41.87
- BDTX $2.43
- Resistance Level
- KTOS $47.09
- BDTX $2.72
- Average True Range (ATR)
- KTOS 2.58
- BDTX 0.18
- MACD
- KTOS -0.06
- BDTX -0.00
- Stochastic Oscillator
- KTOS 63.66
- BDTX 76.11
About KTOS Kratos Defense & Security Solutions Inc.
Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.